top of page

 

 

Patient centered outcomes

  • PROs and other COAs

  • Regulatory and HTA support

  • Instrument development and selection

  • Instrument testing and validation

  • Interpretation of PRO and other COA data

Issues around PRO assessment to support drug development are explored in-depth in a publication co-authored by Annabel Nixon, published by SEEd 2015.

  Statistical consultancy services

bottom of page